JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2012, Vol. 26 ›› Issue (1): 38-40.

• Articles • Previous Articles     Next Articles

Influence of controlled-release formulations in maxillary sinus for chronic sinusitis

CHEN Zhi-peng1, WANG Qi-rong1, CUI Zhao-yang1, CHEN Hai-xia3   

  1.  Department of Otorhinolaryngology, Qianfo Mountain Hospital of Shandong University, Jinan 250014; 2. Department of Pharmaceutical, Qilu Hospital of Shandong University, Jinan 250012
  • Received:2011-12-10 Online:2012-02-16 Published:2012-02-16

Abstract:

Objective   To study the implantation of controlled release formulations of erythromycin treatment of maxillary sinusitis in clinical efficacy. Methods    Controlledrelease formulations of erythromycin were implanted in the maxillary sinus by nasal antrostomy of inferior nasal meatus under endoscopy.  Result   48 sides were detected erythromycin from human nasal secretions after 21 days, and 45 sides reached standards of clinical cure. Conclusion   Clinical application of controlled-release formulations of erythromycin can reduce or stop oral or intravenous drug use, reduce the frequency of postoperative dressing, also reduces the suffering of patients.

Key words: Nasosinusitis; Maxillary sinus; Erythromycin sustained release preparation; Treatment outcome

CLC Number: 

  • R765.4+1
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!